Relmada Therapeutics Inc. (RLMD)
0.26
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
0.24
-5.22%
After-hours: Mar 03, 2025, 06:03 PM EST
Relmada Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.31 | -0.16 | -0.63 | -1.68 | -4.8 | -0.53 | -0.28 | -0.31 | -1.77 | -0.97 | -253.25 | -1.42K |
| PEG Ratio | 0.01 | 0.01 | -0.01 | -0.01 | 0.12 | 0.13 | -0.01 | -0.00 | 0.02 | -0.00 | -0.93 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.22K | 2.15K |
| PB Ratio | 0.36 | 0.18 | 0.38 | 0.95 | 0.62 | 1.21 | -0.46 | 1.36 | 0.75 | 2.29 | -0.21 | 1.51K |
| P/FCF Ratio | -0.6 | -0.25 | -0.86 | -3.59 | -5.95K | -0.88 | -0.42 | -0.3 | -0.39 | -1.24 | -834.61 | -2.26K |
| P/OCF Ratio | -0.6 | -0.25 | -0.86 | -3.59 | -5.95K | -0.88 | -0.42 | -0.31 | -0.4 | -1.24 | -961.3 | -2.26K |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.31 | -0.95 |
| Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.05 | -0.53 | 0.19 | 0.04 | 0.03 | -0.00 | n/a |
| Quick Ratio | 8.00 | 11.94 | 14.08 | 9.30 | 80.21 | 3.65 | 0.39 | 1.45 | 2.86 | 1.45 | 0.96 | 1.71 |
| Current Ratio | 8.00 | 12.26 | 14.83 | 9.37 | 80.21 | 3.83 | 0.46 | 1.80 | 3.04 | 1.54 | 0.96 | 2.62 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.43 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | -5.17 | -13.13K | n/a | -3.47K | n/a | n/a |
| Return on Equity (ROE) | -1.16 | -1.12 | -0.6 | -0.56 | -0.13 | -2.27 | 1.63 | -4.3 | -0.42 | -2.36 | 0.00 | -1.06 |
| Return on Assets (ROA) | -1.01 | -1.03 | -0.56 | -0.5 | -0.13 | -1.69 | -2.94 | -2.22 | -0.29 | -0.85 | -0.00 | -0.66 |
| Return on Capital (ROIC) | -1.21 | -1.15 | -0.6 | -0.58 | -0.13 | -1.67 | 2.42 | -4.94 | -2.26 | -1.94 | 0.04 | -1.06 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.31% | 26.97% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -266.31% | -95.27% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -147.02% |